$1 Million Bet On OmniAb? Check Out These 3 Penny Stocks Insiders Are Buying


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


The Dow Jones closed lower by around 200 points on Thursday. Investors, meanwhile, focused on some notable insider trades.

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

DiaMedica Therapeutics

  • The Trade: DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Director Michael Randall Giuffre bought a total of 67,228 shares at an average price of $1.20. To acquire these shares, it cost around $80.46 thousand.
  • What’s Happening: DiaMedica Therapeutics, last month, posted a Q3 loss of $0.12 per share.
  • What DiaMedica Therapeutics Does: DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company.

 


FREE REPORT: How To Learn Options Trading Fast

In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, ​a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.


OmniAb

  • The Trade: OmniAb, Inc. (NASDAQ:OABI) President and CEO Matthew Foehr acquired a total of 300,000 shares at an average price of $3.39. The insider spent around $1.02 million to buy those shares.
  • What’s Happening: SVB Leerink recently initiated coverage on OmniAb with an Outperform rating and announced a price target of $6.
  • What OmniAb Does: OmniAb offers best-in-class therapeutic antibody discovery technologies.

Investor Sentiment Drops Ahead Of US Jobs Report

Don’t forget to check out our premarket coverage here .

 

Ballantyne Strong

  • The Trade: Ballantyne Strong, Inc (NYSE:BTN) 10% owner Ballantyne Strong Holdings, LLC acquired a total of 9,486 shares at an average price of $2.45. To acquire these shares, it cost around $23.2 thousand.
  • What’s Happening: The company, last month, swung to a loss in the third quarter.
  • What Ballantyne Strong Does: Ballantyne Strong Inc manufactures and distributes projection screens and provides technical support services and other related products and services to the cinema exhibition industry, theme parks, schools, museums, and other entertainment-related markets.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: Long IdeasNewsPenny StocksSmall CapInsider TradesMarketsTrading IdeasInsider Buying